tiprankstipranks
PharmaSGP Holding SE (DE:PSG)
XETRA:PSG
Germany Market

PharmaSGP Holding SE (PSG) Stock Price & Analysis

2 Followers

PSG Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€16.65 - €27.76
Previous Close€23.2
Volume617.00
Average Volume (3M)713.00
Market Cap
€278.40M
Enterprise Value€250.33M
Total Cash (Recent Filing)€29.37M
Total Debt (Recent Filing)€1.30M
Price to Earnings (P/E)15.4
Beta-0.18
Sep 26, 2024
Dividend Yield2.11%
Share Statistics
EPS (TTM)1.51
Shares Outstanding12,000,000
10 Day Avg. Volume440
30 Day Avg. Volume713
Standard Deviation0.10
R-Squared0.00027
Alpha-0.00249
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
Price Target Upside61.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2

Financials

Annual

PSG FAQ

What was PharmaSGP Holding SE’s price range in the past 12 months?
PharmaSGP Holding SE lowest stock price was €16.65 and its highest was €27.75 in the past 12 months.
    What is PharmaSGP Holding SE’s market cap?
    Currently, no data Available
    When is PharmaSGP Holding SE’s upcoming earnings report date?
    PharmaSGP Holding SE’s upcoming earnings report date is Sep 26, 2024 which is in 87 days.
      How were PharmaSGP Holding SE’s earnings last quarter?
      Currently, no data Available
      Is PharmaSGP Holding SE overvalued?
      According to Wall Street analysts PharmaSGP Holding SE’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does PharmaSGP Holding SE pay dividends?
        PharmaSGP Holding SE pays a Annually dividend of €1.36 which represents an annual dividend yield of 2.11%. See more information on PharmaSGP Holding SE dividends here
          What is PharmaSGP Holding SE’s EPS estimate?
          PharmaSGP Holding SE’s EPS estimate is €0.41.
            How many shares outstanding does PharmaSGP Holding SE have?
            PharmaSGP Holding SE has 12,000,000 shares outstanding.
              What happened to PharmaSGP Holding SE’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of PharmaSGP Holding SE?
              Currently, no hedge funds are holding shares in DE:PSG
              ---

              PharmaSGP Holding SE Stock Smart Score

              Company Description

              PharmaSGP Holding SE

              PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical free, over-the-counter (OTC) drugs and healthcare products. The product portfolio includes RUBAXX for rheumatic pain and Restaxil for nerve pain, and Deseo for sexual dysfunction. Also, the company offers products for skin aging and vertigo.
              ---

              PSG Stock 12 Month Forecast

              Average Price Target

              €37.42
              ▲(61.29% Upside)
              {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"€20","39":"€39","24.75":"€24.8","29.5":"€29.5","34.25":"€34.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">€38.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":37.42,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">€37.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.847575,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">€36.85</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,24.75,29.5,34.25,39],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2023","6":"Apr<br/>2023","9":"Jun<br/>2023","12":"Jun<br/>2024","25":"Jun<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.26,22.54769230769231,23.835384615384616,25.123076923076923,26.410769230769233,27.698461538461537,28.986153846153847,30.273846153846154,31.56153846153846,32.84923076923077,34.136923076923075,35.424615384615386,36.71230769230769,{"y":38,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.26,22.503076923076925,23.74615384615385,24.989230769230772,26.232307692307693,27.47538461538462,28.71846153846154,29.961538461538463,31.204615384615387,32.44769230769231,33.690769230769234,34.933846153846154,36.17692307692308,{"y":37.42,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.26,22.459044230769234,23.658088461538462,24.857132692307694,26.056176923076926,27.255221153846154,28.454265384615386,29.653309615384615,30.852353846153846,32.05139807692308,33.25044230769231,34.44948653846154,35.64853076923077,{"y":36.847575,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":23.1,"date":1664582400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.1,"date":1667260800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.56,"date":1669852800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.3,"date":1672531200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.84,"date":1675209600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.93,"date":1677628800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.7,"date":1680307200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.52,"date":1682899200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.76,"date":1685577600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.06,"date":1688083200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.03,"date":1688688000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.22,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.26,"date":1718323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
              Similar Stocks
              Company
              Price & Change
              Follow
              Dermapharm Holding SE
              ATAI Life Sciences
              APONTIS PHARMA AG
              MPH Health Care AG

              Best Analysts Covering PSG

              1 Year
              1 Year Success Rate
              1/1 ratings generated profit
              100%
              1 Year Average Return
              +9.10%
              reiterated a buy rating 17 days ago
              Copying Jack Reynolds-Clark's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.10% per trade.
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis